Adicet bio to participate in upcoming investor conferences

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for autoimmune diseases and cancer, today announced that company management will participate in three upcoming investor conferences in november. details of the events are as follows: truist securities biopharma symposium, november 7, 2024, new york, ny members of management will be available for 1x1 meetings on.
ACET Ratings Summary
ACET Quant Ranking